International Clinical Trial: Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07816809) titled 'Phage-based Control and Limitation of Pathobionts for Microbiome Equilibrium and Resilience' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Supportive Care. Masking: Double (Participant, Investigator).

Primary Sponsor: Colorado State University

Condition: Gastrointestinal Symptoms Skin Quality

Intervention: Dietary Supplement: Bacteriophages - MuniPhage Dietary Supplement: Bacteriophages - RenuPhage

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: September 14, 2026

Target Sample Size: 40

Countr...